Clinical Trial Update: Peg-interferon ADDed to an Ongoing Nucleos(t)Ide Based Treatment in Patients With Chronic Hepatitis B to Induce Decrease of HBs-Antigen [Phase 2]

View source ↗

Summary

Phase 2 trial investigating addition of peg-interferon to nucleos(t)ide-based therapy in chronic hepatitis B to reduce HBs antigen; completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Peg-interferon (pegylated interferon alfa)

Snippet

Sponsor: Johannes Gutenberg University Mainz | Conditions: Chronic Hepatitis B | Phase 2 | Status: COMPLETED | Results posted: 2020-02-18